Ultima Vez Modificado: 1 de noviembre del 2001
May 21, 2012 - For pediatric patients with tumors that have genetic aberrations in the anaplastic lymphoma kinase gene, crizotinib is well tolerated and has antitumor activity, according to a study released May 16 in advance of presentation at the annual meeting of the American Society of Clinical Oncology, held from June 1 to 5 in Chicago.
Sep 24, 2010
Jan 17, 2013
Oct 17, 2012
Apr 19, 2014